Betulinic acid enhances 1alpha,25-dihydroxyvitamin D3-induced differentiation in human HL-60 promyelocytic leukemia cells

Anticancer Drugs. 2004 Jul;15(6):619-24. doi: 10.1097/01.cad.0000132237.15427.23.

Abstract

Betulinic acid (BA) is a pentacyclic triterpene found in a number of medicinal plants and has been shown to cause apoptosis in a number of cell lines. We report here that BA may also have an effect on HL-60 cell differentiation. BA was cytotoxic to HL-60 cells with an IC50 of 5.7 microM after a 72-h treatment. Flow cytometry analysis showed that after exposure to 1-12 microM of BA for 72 h, approximately 10% of viable cells were in the sub-G1, presumably apoptotic, phase. At the same time differentiation was induced in approximately 10% (at 1 microM BA) to a maximum of 20% (at 6 microM BA) of cells as judged by the NBT-reduction test, and the expression of membrane markers CD11b and CD14. On the other hand, at 1 and 5 nM, 1alpha,25-dihydroxyvitamin D3 (DHD3) induced differentiation in approximately 10 and 70% of cells, respectively. At 1 nM DHD3, the addition of 1 microM BA increased differentiated cells from 10 to 43% and with 3 microM BA the increase was to 80%. BA also enhanced the effects of DHD3 in the expansion of the G1 cell population with a concomitant decrease of S phase cells. The effects of DHD3 and BA on CD11b and CD14 expression were inhibited by PD98059, a MEK inhibitor. Our results suggest that BA may enhance the effect of DHD3 in inducing mitogen-activated protein kinase kinase/extracellular signal-regulated protein kinase-mediated HL-60 cell differentiation.

Publication types

  • Comparative Study

MeSH terms

  • Apoptosis / drug effects
  • Betulinic Acid
  • CD11b Antigen / biosynthesis
  • CD11b Antigen / genetics
  • Calcitriol / pharmacology*
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Enzyme Activation / drug effects
  • Enzyme Activation / genetics
  • Enzyme Activation / physiology
  • Flavonoids / pharmacology
  • G1 Phase / drug effects
  • G1 Phase / physiology
  • Gene Expression / drug effects
  • Gene Expression / genetics
  • HL-60 Cells / cytology*
  • Humans
  • Lipopolysaccharide Receptors / biosynthesis
  • Lipopolysaccharide Receptors / genetics
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase Kinases / drug effects
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Monocytes / cytology
  • Monocytes / drug effects
  • Pentacyclic Triterpenes
  • Triterpenes / antagonists & inhibitors
  • Triterpenes / chemistry
  • Triterpenes / pharmacology*

Substances

  • CD11b Antigen
  • Flavonoids
  • Lipopolysaccharide Receptors
  • Pentacyclic Triterpenes
  • Triterpenes
  • Mitogen-Activated Protein Kinase Kinases
  • Calcitriol
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Betulinic Acid